Can metabolomics be used for assessing nutritive-dependent human diseases?

Oliver Fiehn, Joachim Spranger

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Metabolomic approaches are taking place within emerging technologies that share the focus to unravel unexpected effects in classical biological experiments, for example mutant/wild type comparisons. This review highlights the possibility of metabolomics going beyond this stage and comparing the onset and the pathogenesis of complex diseases, such as type 2 diabetes mellitus, in large scale projects that might reach out to compare different populations and different nutritional diets and interventions. The steps of validation that are needed to pursue such projects are described, and the range of analytical and computational approaches that can be utilized are discussed. Using type 2 diabetes mellitus, it is emphasized that there is a high economic and scientific need to reliably diagnose and predict metabolic diseases in a cost effective manner.

Original languageEnglish (US)
Pages (from-to)223-230
Number of pages8
JournalPhytochemistry Reviews
Volume1
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Metabolomics
metabolomics
human diseases
noninsulin-dependent diabetes mellitus
Type 2 Diabetes Mellitus
Metabolic Diseases
metabolic diseases
pathogenesis
Economics
Diet
Technology
Costs and Cost Analysis
economics
mutants
diet
Population

Keywords

  • Diabetes mellitus
  • Mass spectrometry
  • Metabolomics
  • Pattern recognition

ASJC Scopus subject areas

  • Molecular Medicine
  • Plant Science
  • Biotechnology

Cite this

Can metabolomics be used for assessing nutritive-dependent human diseases? / Fiehn, Oliver; Spranger, Joachim.

In: Phytochemistry Reviews, Vol. 1, No. 2, 2002, p. 223-230.

Research output: Contribution to journalArticle

Fiehn, Oliver ; Spranger, Joachim. / Can metabolomics be used for assessing nutritive-dependent human diseases?. In: Phytochemistry Reviews. 2002 ; Vol. 1, No. 2. pp. 223-230.
@article{ae85be4f2ed64cf5b0912d902e162b13,
title = "Can metabolomics be used for assessing nutritive-dependent human diseases?",
abstract = "Metabolomic approaches are taking place within emerging technologies that share the focus to unravel unexpected effects in classical biological experiments, for example mutant/wild type comparisons. This review highlights the possibility of metabolomics going beyond this stage and comparing the onset and the pathogenesis of complex diseases, such as type 2 diabetes mellitus, in large scale projects that might reach out to compare different populations and different nutritional diets and interventions. The steps of validation that are needed to pursue such projects are described, and the range of analytical and computational approaches that can be utilized are discussed. Using type 2 diabetes mellitus, it is emphasized that there is a high economic and scientific need to reliably diagnose and predict metabolic diseases in a cost effective manner.",
keywords = "Diabetes mellitus, Mass spectrometry, Metabolomics, Pattern recognition",
author = "Oliver Fiehn and Joachim Spranger",
year = "2002",
doi = "10.1023/A:1022567619029",
language = "English (US)",
volume = "1",
pages = "223--230",
journal = "Phytochemistry Reviews",
issn = "1568-7767",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Can metabolomics be used for assessing nutritive-dependent human diseases?

AU - Fiehn, Oliver

AU - Spranger, Joachim

PY - 2002

Y1 - 2002

N2 - Metabolomic approaches are taking place within emerging technologies that share the focus to unravel unexpected effects in classical biological experiments, for example mutant/wild type comparisons. This review highlights the possibility of metabolomics going beyond this stage and comparing the onset and the pathogenesis of complex diseases, such as type 2 diabetes mellitus, in large scale projects that might reach out to compare different populations and different nutritional diets and interventions. The steps of validation that are needed to pursue such projects are described, and the range of analytical and computational approaches that can be utilized are discussed. Using type 2 diabetes mellitus, it is emphasized that there is a high economic and scientific need to reliably diagnose and predict metabolic diseases in a cost effective manner.

AB - Metabolomic approaches are taking place within emerging technologies that share the focus to unravel unexpected effects in classical biological experiments, for example mutant/wild type comparisons. This review highlights the possibility of metabolomics going beyond this stage and comparing the onset and the pathogenesis of complex diseases, such as type 2 diabetes mellitus, in large scale projects that might reach out to compare different populations and different nutritional diets and interventions. The steps of validation that are needed to pursue such projects are described, and the range of analytical and computational approaches that can be utilized are discussed. Using type 2 diabetes mellitus, it is emphasized that there is a high economic and scientific need to reliably diagnose and predict metabolic diseases in a cost effective manner.

KW - Diabetes mellitus

KW - Mass spectrometry

KW - Metabolomics

KW - Pattern recognition

UR - http://www.scopus.com/inward/record.url?scp=26244442828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26244442828&partnerID=8YFLogxK

U2 - 10.1023/A:1022567619029

DO - 10.1023/A:1022567619029

M3 - Article

AN - SCOPUS:26244442828

VL - 1

SP - 223

EP - 230

JO - Phytochemistry Reviews

JF - Phytochemistry Reviews

SN - 1568-7767

IS - 2

ER -